Blade Therapeutics

United States
South San Francisco, California, United States, 94080

Company profile

Blade Therapeutics company profile

Blade Therapeutics is a discovery stage drug development company. Their mission is to create antifibrotic treatment strategies that address a wide variety of congenital and acquired diseases of fibrosis. Their leadership team has extensive experience at developing drugs that treat fibrotic disorders. They are also partnering with international experts in order to identify and in-license cutting-edge technologies to build a robust pipeline of antifibrotic compounds.

Business identity

Phone number
+1 650 278 4291
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2013-01-01, Year

Headquarters

Postal code
94080
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
4
Total equity funding
$51.5M
Last funding
Series Unknown / 2018-11-13
Last equity funding
Series Unknown
Investors
7
Lead investors
2
Founders
1
Articles
19

Founders and investors

Founders

Harry Dietz

Lead investors

DeerfieldMPM Capital

Investors

Bristol-Myers SquibbDeerfieldMPM CapitalOneVenturesOUP (Osage University Partners)